Market Place
Sourcing Support
FDA ups Boston Scientific cryoablation recall tied to 4 deaths
20 Dec 2024 //
FIERCE BIOTECH
Boston Scientific to buy chemo pump implant for liver tumors
25 Nov 2024 //
FIERCE BIOTECH
Boston Scientific, Abbott tout long-term heart occluder data
19 Nov 2024 //
FIERCE BIOTECH
Boston Scientific Closes Acquisition of Axonics, Inc.
19 Nov 2024 //
PRESS RELEASE
Boston Scientific resumes Farapulse study in first-line afib
11 Nov 2024 //
FIERCE BIOTECH
US FDA approves Johnson & Johnson`s device for heart condition
08 Nov 2024 //
REUTERS
Boston Scientific bolsters pulsed field ablation with Cortex buy
04 Nov 2024 //
FIERCE BIOTECH
Boston Scientific`s CMO takes the pulse of pulsed field ablation
29 Oct 2024 //
FIERCE BIOTECH
Boston Scientific posts 177% EP growth, pauses Farapulse study
23 Oct 2024 //
FIERCE BIOTECH
FDA OKs Boston Scientific’s nav-equipped pulsed field catheter
21 Oct 2024 //
FIERCE BIOTECH
Boston Sci creates docuseries to destigmatize male incontinence
16 Oct 2024 //
FIERCE PHARMA
Boston Scientific Gets PDMA Approval In Japan For FARAPULSE
30 Sep 2024 //
PHARMABIZ
Boston Scientific nets earlier-than-expected TAVR approval in Europe
27 Aug 2024 //
FIERCE BIOTECH
Boston Scientific to buy Silk Road Medical in $1.16 billion deal
19 Jun 2024 //
REUTERS
Modular ATP study of the mCRM System meets primary safety and efficacy endpoints
21 May 2024 //
INDINPHARMAPOST
FDA elevates catheter recalls from Boston Scientific, Route 92
14 May 2024 //
FIERCE BIOTECH
FDA classifies recall of Boston Scientific device as `most serious`
18 Apr 2024 //
REUTERS
FTC asks Boston Scientific, Axonics for more info on $3.7B deal
04 Apr 2024 //
FIERCE BIOTECH
J&J in talks to buy Shockwave Medical, WSJ reports
26 Mar 2024 //
REUTERS
US FDA approves Boston Scientific`s drug-coated heart device
01 Mar 2024 //
REUTERS
Bos Sci nets first US approval for drug-coated coronary balloon
01 Mar 2024 //
FIERCE BIOTECH
Boston Scientific shielded from weight-loss drugs hit by procedure recovery
25 Oct 2023 //
REUTERS
Boston Scientific to buy chronic back pain therapy maker Relievant
19 Sep 2023 //
REUTERS
ADVENT Study of FARAPULSE Pulsed Field Ablation System Meets Primary Efficacy
27 Aug 2023 //
PR NEWSWIRE
US FDA approves Boston Scientific’s POLARx Cryoablation System
09 Aug 2023 //
PHARMABIZ
Boston Scientific lifts annual profit forecast on heart devices strength
27 Jul 2023 //
REUTERS
Boston Scientific lays off 52 amid California facility closure
19 Jul 2023 //
FIERCE BIOTECH
Boston Scientific nixes $230M M.I.Tech acquisition
25 May 2023 //
FIERCE BIOTECH
Boston Scientific fined $42M in stent patent lawsuit
03 Feb 2023 //
FIERCE BIOTECH
Boston Scientific sets down $523M for control of China’s Acotec
12 Dec 2022 //
FIERCEBIOTECH
Boston Scientific snatches up gastro-focused Apollo for $615M
29 Nov 2022 //
FIERCEBIOTECH
Boston Scientific expands operations in Malaysia
15 Nov 2022 //
BIOSPECTRUMASIA
Boston Scientific`s Sentinel misses endpoint in reducing strokes
19 Sep 2022 //
FIERCEBIOTECH
Wipro, Boston join hands to provide cardiac care solutions in India
17 Aug 2022 //
ECONOMICS TIMES
Boston Scientific acquires hydrogel maker Obsidio
15 Aug 2022 //
FIERCEBIOTECH
Boston Scientific buys $230M worth stake in Korean medtech firm
17 Jun 2022 //
BIOSPECTRUMASIA
Boston Scientific offers $230M for Korean stent maker
15 Jun 2022 //
FIERCEBIOTECH
Boston Scientific would be ‘good fit’ for increasingly acquisitive J&J
31 May 2022 //
MEDTECHDIVE
Abbott’s Amulet, Boston Scientific’s Watchman devices are riskier for women
19 May 2022 //
MEDTECHDIVE
Boston Scientific co-founder, former CEO Peter Nicholas dies at 80
16 May 2022 //
FIERCEBIOTECH
Boston Scientific surges 10% in Q1 amid slew of FDA nods, company reorganization
27 Apr 2022 //
FIERCEBIOTECH
Boston Scientific closes acquisition of Baylis Medical Company
16 Feb 2022 //
PHARMABIZ
Boston Scientific posts 15% gain in Q4 sales, expects `headwinds` in 2022
03 Feb 2022 //
MEDTECHDIVE
Boston Scientific to lay off 170 California workers
14 Dec 2021 //
FIERCEBIOTECH
Neurostimulator to treat stroke fails to gain FDA advisory panel support
13 Dec 2021 //
MEDTECHDIVE
Boston Scientific to test modular, leadless pacemaker-ICD system
03 Dec 2021 //
FIERCEBIOTECH
Latest Abbott, Boston Scientific LAAC devices yield mixed results
08 Nov 2021 //
MEDTECHDIVE
Boston Scientific wins $20M patent infringement case against Nevro
03 Nov 2021 //
FIERCEBIOTECH
Abbott`s COVID test sales make comeback with delta-driven demand
21 Oct 2021 //
FIERCEBIOTECH
J&J delays Ottava robot rollout as global medtech business boosts Q3 sales
19 Oct 2021 //
MEDTECHDIVE
FEops HEARTguide Authorized by FDA for Unprecedented LAAo Planning Capabilities
14 Oct 2021 //
BIOSPACE
Medtechs opened 2021 with a flurry of M&A and have not stopped spending since
07 Oct 2021 //
MEDTECHDIVE
Boston Scientific puts down $1.7B to scoop up Baylis Medical
07 Oct 2021 //
FIERCEBIOTECH
Boston Scientific says Eluvia was 85% effective for arterial diseases
06 Oct 2021 //
SEEKINGALPHA
FDA medical device regs, safety checks questioned by AMA ethics journal
29 Sep 2021 //
MEDTECHDIVE
Boston Scientific offers up $336M to devour Devoro Medical
22 Sep 2021 //
FIERCEBIOTECH
Boston Scientific adds colorectal cancer boost to tumor-targeting microbeads
20 Sep 2021 //
FIERCEBIOTECH
Doctor, surgical funder admit to roles in transvaginal mesh fraud
17 Sep 2021 //
REUTERS
Boston Scientific closes acquisition of Lumenis’ surgical business
03 Sep 2021 //
PHARMABIZ
Abbott`s Amplatzer Amulet Occluder offers LAA closure in patients with AF
01 Sep 2021 //
PHARMABIZ
